Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,024 | -26,651 | -22,748 | -7,468 | -24,994 |
| Depreciation Amortization | 1,184 | 502 | 373 | 244 | 1,135 |
| Accounts receivable | 954 | 884 | 881 | 632 | -1,118 |
| Other Working Capital | 13,603 | 14,040 | 13,425 | 3,376 | 607 |
| Other Operating Activity | 55 | -168 | -397 | -388 | 1,856 |
| Operating Cash Flow | $-14,227 | $-11,393 | $-8,466 | $-3,604 | $-22,514 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 10,000 |
| PPE Investments | -262 | -148 | -111 | -130 | -6,203 |
| Investing Cash Flow | $-262 | $-148 | $-111 | $-130 | $3,797 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,905 | 6,530 | 3,700 | 1,750 | N/A |
| Debt Repayment | -119 | -88 | -59 | -30 | -38 |
| Common Stock Issued | 8,783 | 2,502 | 2,502 | 2,502 | 24 |
| Financing Cash Flow | $15,569 | $8,944 | $6,143 | $4,223 | $-15 |
| Beginning Cash Position | 3,595 | 3,595 | 3,595 | 3,595 | 22,326 |
| End Cash Position | 4,675 | 998 | 1,161 | 4,084 | 3,595 |
| Net Cash Flow | $1,080 | $-2,597 | $-2,434 | $489 | $-18,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,227 | -11,393 | -8,466 | -3,604 | -22,514 |
| Capital Expenditure | -262 | -148 | -111 | -130 | -6,203 |
| Free Cash Flow | -14,489 | -11,541 | -8,577 | -3,734 | -28,717 |